StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Fidelity 22 and Penson 5

<< Previous

Bullboard Posts

Next >>

Comment by LithLoveron Sep 09, 2021 3:23pm

145 Views

Post# 33834728

RE:Fidelity 22 and Penson 5

Another very strange situation is that the TSX is less than half the overall volume. This has been happening more and more of late.

So far today 84,400 in volume and TSX is only 37,700 of that (45%)

It's just more quiet accumulation by certain houses on certain exchanges.

Photoman77 wrote: Fidelity 22 and Penson 5 seem to be buying together today. Not sure if this has been a trend but it seems to be the same buyer buying through two accounts at the same time.

<< Previous

Bullboard Posts

Next >>

Transportation technology stock secures second major contract in a week